Integrated Investment Consultants’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$385K Sell
727
-187
-20% -$86.3K 0.08% 169
2026
Q1
$439K Sell
914
-677
-43% -$347K 0.09% 142
2025
Q4
$894K Sell
1,591
-158
-9% -$89.7K 0.18% 93
2025
Q3
$899K Sell
1,749
-423
-19% -$185K 0.15% 94
2025
Q2
$682K Sell
2,172
-13
-0.6% -$3.9K 0.13% 114
2025
Q1
$666K Buy
2,185
+1,493
+216% +$502K 0.13% 117
2024
Q4
$230K Buy
692
+39
+6% +$13.2K 0.05% 273
2024
Q3
$218K Buy
653
+15
+2% +$5.7K 0.05% 274
2024
Q2
$258K Hold
638
– – 0.07% 216
2024
Q1
$258K Buy
+638
New +$224K 0.07% 216

Other funds holding MEDP

Integrated Investment Consultants's MEDP Position: Q2 2026 in Review

Integrated Investment Consultants reduced its Medpace (MEDP) stake by 20% in Q2 2026, selling an estimated $86.3K and leaving 727 shares worth $385K. The position accounts for 0.08% of the portfolio, ranked #169.

Integrated Investment Consultants first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. The position peaked at $899K in Q3 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Integrated Investment Consultants held 727 shares of Medpace worth $385K as of Q2 2026.
  • Integrated Investment Consultants sold 187 Medpace shares in Q2 2026, an estimated $86.3K.
  • Medpace made up 0.08% of Integrated Investment Consultants's portfolio in Q2 2026, its #169 holding.
  • Integrated Investment Consultants first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • Integrated Investment Consultants's Medpace position peaked at $899K in Q3 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Integrated Investment Consultants's 13F filing for Q2 2026, filed 17 Aug 2026.